Cargando…

The pathway to secondary prevention of Alzheimer's disease

Alzheimer's disease (AD) is a continuum consisting of a preclinical stage that occurs decades before symptoms appear. As researchers make advances in investigating the continuum, the importance of developing drugs for secondary prevention is garnering increased discussion. For efficacious drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDade, Eric, Bednar, Martin M., Brashear, H. Robert, Miller, David S., Maruff, Paul, Randolph, Christopher, Ismail, Zahinoor, Carrillo, Maria C., Weber, Christopher J., Bain, Lisa J., Hake, Ann Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453146/ https://www.ncbi.nlm.nih.gov/pubmed/32885024 http://dx.doi.org/10.1002/trc2.12069

Ejemplares similares

Building clinically relevant outcomes across the Alzheimer's disease spectrum
por: Rentz, Dorene M., et al.
Publicado: (2021)

Measuring cognition and function in the preclinical stage of Alzheimer's disease
por: Weintraub, Sandra, et al.
Publicado: (2018)

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
por: Rabinovici, Gil D., et al.
Publicado: (2016)

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations
por: Petersen, Ronald C., et al.
Publicado: (2023)

Advancing combination therapy for Alzheimer's disease
por: Salloway, Stephen P., et al.
Publicado: (2020)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

From society to cells and back again: new opportunities for discovery at the biosocial interface
por: McDade, Thomas W., et al.
Publicado: (2022)

Concise informed consent to increase data and biospecimen access may accelerate innovative Alzheimer's disease treatments
por: Hake, Ann M., et al.
Publicado: (2017)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank
por: Vitek, Michael P., et al.
Publicado: (2021)

Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials
por: Gold, Michael, et al.
Publicado: (2018)

Reconsidering frameworks of Alzheimer's dementia when assessing psychosocial outcomes
por: Gaugler, Joseph E., et al.
Publicado: (2019)

The informed road map to prevention of Alzheimer Disease: A call to arms
por: McDade, Eric, et al.
Publicado: (2021)

Legionella and the Prevention of Legionellosis
por: McDade, Joseph E.
Publicado: (2008)

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
por: Lopez Lopez, Cristina, et al.
Publicado: (2019)

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives
por: Weber, Christopher J., et al.
Publicado: (2021)

Flavonoids and Their Metabolites: Prevention in Cardiovascular Diseases and Diabetes
por: Zeka, Keti, et al.
Publicado: (2017)

Finding effective combinations of compounds to prevent Alzheimer’s disease
por: Dhakal, Sudip, et al.
Publicado: (2022)

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
por: Strydom, André, et al.
Publicado: (2018)

Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer's disease
por: Ahmed, Heba A., et al.
Publicado: (2021)

Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers
por: Norwitz, Nicholas G., et al.
Publicado: (2021)

Could lysine supplementation prevent Alzheimer’s dementia? A novel hypothesis
por: Rubey, Robert N
Publicado: (2010)

New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge
por: Piemontese, Luca
Publicado: (2017)

Determining the mechanism behind yoga’s effects on preventing the symptoms of Alzheimer’s disease
por: Hassan, Adithy, et al.
Publicado: (2019)

Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseases
por: Sánchez-Pérez, Ana María
Publicado: (2019)

Digital Health in Cardiac Rehabilitation and Secondary Prevention: A Search for the Ideal Tool
por: Falter, Maarten, et al.
Publicado: (2020)

Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer’s disease prevention
por: Gopalakrishna, Rayudu, et al.
Publicado: (2023)

Supplemental thiamine as a practical, potential way to prevent Alzheimer's disease from commencing
por: Fessel, Jeffrey
Publicado: (2021)

A vaccine to prevent initial loss of cognition and eventual Alzheimer's disease in elderly persons
por: Fessel, Jeffrey
Publicado: (2021)

Decision making in clinical trials: Interim analyses, innovative design, and biomarkers
por: Welsh‐Bohmer, Kathleen A., et al.
Publicado: (2023)

Neisseria Cinerea Bacteremia Secondary to a Retropharyngeal Abscess
por: McDade, Kaitlin, et al.
Publicado: (2021)

Waterborne Outbreaks in Hemodialysis Patients and Infection Prevention
por: Kanamori, Hajime, et al.
Publicado: (2022)

Addressing the potential threat of bioterrorism--value added to an improved public health infrastructure.
por: McDade, J E
Publicado: (1999)

Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease
por: Creese, Byron, et al.
Publicado: (2022)

Alzheimer disease in African American individuals: increased incidence or not enough data?
por: Barnes, Lisa L.
Publicado: (2021)

A general neurologist's perspective on the urgent need to apply resilience thinking to the prevention and treatment of Alzheimer's disease
por: Pomorska, Grazyna, et al.
Publicado: (2017)

Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs
por: Fessel, Jeffrey
Publicado: (2019)

Health economic modeling for Alzheimer's disease: Expert perspectives
por: Landeiro, Filipa, et al.
Publicado: (2022)

Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia
por: Alphs, Larry, et al.
Publicado: (2016)

Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID‐19 pandemic
por: Meyers, Emily A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_57rsetm16e9kd3shq6cpmpjr1f